Want to see TSE:PREV full AI Analyst Report?
PreveCeutical Medical (PREV) Stock Statistics & Valuation Metrics
Total Valuation
PreveCeutical Medical has a market cap or net worth of CAD 12.76M. The enterprise value is CAD 13.85M.
- Market Cap
- CAD 12.76M
- Enterprise Value
- CAD 13.85M
Share Statistics
PreveCeutical Medical has 638,186,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 638,186,950
- Owned by Insiders
- 19.30%
- Owned by Institutions
- ―
Financial Efficiency
PreveCeutical Medical’s return on equity (ROE) is 0.25 and return on invested capital (ROIC) is 339.03%.
- Return on Equity (ROE)
- 0.25
- Return on Assets (ROA)
- -1.09
- Return on Invested Capital (ROIC)
- 339.03%
- Return on Capital Employed (ROCE)
- 0.59
- Revenue Per Employee
- 0
- Profits Per Employee
- -316.86K
- Employee Count
- 5
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of PreveCeutical Medical is -16.67. PreveCeutical Medical’s PEG ratio is -0.15.
- PE Ratio
- -16.67
- PS Ratio
- 0.00
- PB Ratio
- -1.80
- Price to FCF
- -7.97
- Price to Operating Cash Flow
- -7.54
- PEG Ratio
- -0.15
Income Statement
In the last 12 months, PreveCeutical Medical had revenue of 0 and earned -1.58M in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- -14.43K
- Operating Income
- -3.37M
- Pretax Income
- -1.69M
- Net Income
- -1.58M
- EBITDA
- -1.35M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -1.60M and capital expenditures -6, giving a free cash flow of -1.60M billion.
- Operating Cash Flow
- -1.60M
- Free Cash Flow
- -1.60M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
PreveCeutical Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -12.55%
- Earnings Yield
- -5.69%
Stock Price Statistics
- Beta
- -0.48
- 52-Week Price Change
- -60.00%
- 50-Day Moving Average
- 0.02
- 200-Day Moving Average
- 0.02
- Relative Strength Index (RSI)
- 53.45
- Average Volume (3m)
- 235.58K
Important Dates
PreveCeutical Medical upcoming earnings date is Nov 19, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 28, 2026
- Next Earnings Date
- Nov 19, 2026
- Ex-Dividend Date
- ―
Financial Position
PreveCeutical Medical as a current ratio of 0.15, with Debt / Equity ratio of -74.89%
- Current Ratio
- 0.15
- Quick Ratio
- 0.15
- Debt to Market Cap
- 0.33
- Net Debt to EBITDA
- -3.45
- Interest Coverage Ratio
- -10.44
Taxes
In the past 12 months, PreveCeutical Medical has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
PreveCeutical Medical EV to EBITDA ratio is -64.48, with an EV/FCF ratio of -10.97.
- EV to Sales
- 0.00
- EV to EBITDA
- -64.48
- EV to Free Cash Flow
- -10.97
- EV to Operating Cash Flow
- -10.97
Balance Sheet
PreveCeutical Medical has CAD 35.66K in cash and marketable securities with CAD 4.84M in debt, giving a net cash position of -CAD 4.81M billion.
- Cash & Marketable Securities
- CAD 35.66K
- Total Debt
- CAD 4.84M
- Net Cash
- -CAD 4.81M
- Net Cash Per Share
- -CAD 0.01
- Tangible Book Value Per Share
- -CAD 0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for PreveCeutical Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -36.36%
Scores
- Smart Score
- ―
- AI Score
- 47